ALLRBULLISH, It's supper undervalued. $19-$20 cash on hand, 1 million float, 1.4 million O/S, The company confirmed there will be zero need to dilute via ATM offering. They recently got granted EPO patent, FDA news should be out very soon.
2 gaps need to filled on the way up, keep an eye on it. with $
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2,221.83 USD
−11.90 M USD
0.00 USD
939.47 K
About Allarity Therapeutics, Inc.
Sector
CEO
Thomas H. Jensen
Headquarters
Boston
Website
Founded
2021
FIGI
BBG012NXCZP8
Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company operates in two geographic areas: Denmark and the United States. The company was founded on April 4, 2021 and is headquartered in Boston, MA.
Squeeze?NASDAQ:ALLR
Potential trade setup:
Short interest:
According to fintel it has 360% short interest however that is likely untrue (but don't fade what other people see, retail may see that number and foam at the mouth) as other sources like finviz and market beat state 4-7%.
Open gaps:
No open g
$ALLR Is It A Noteworthy Drug Stock?The five-year mortality rate for women with metastasized breast cancer is 30%. However, that statistic figure may soon be curbed due to Allarity Therapeutics, Inc.’s (NASDAQ: ALLR) new treatment – IXEMPRA-DRP. This is a treatment system combining Ixempra, an FDA-approved treatment for Metastasized b
Allarity priming itself for a pumpAs with most micro biotech companies, I expect the price to continue to fall to the $1 region and then “flatten out” for a while to keep its head just above the minimum listing requirement. It will then probably remain there until it is seemingly forgotten.
Then, in a move to regain compliance (if i
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALLR is 1.35 USD — it has decreased by −3.57% in the past 24 hours. Watch Allarity Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Allarity Therapeutics, Inc. stocks are traded under the ticker ALLR.
ALLR stock has fallen by −2.17% compared to the previous week, the month change is a −15.09% fall, over the last year Allarity Therapeutics, Inc. has showed a −99.55% decrease.
ALLR reached its all-time high on Dec 21, 2021 with the price of 15,288,000.00 USD, and its all-time low was 1.26 USD and was reached on Oct 30, 2024. View more price dynamics on ALLR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALLR stock is 6.02% volatile and has beta coefficient of 2.52. Track Allarity Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Allarity Therapeutics, Inc. there?
Yes, you can track Allarity Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Allarity Therapeutics, Inc. is going to release the next earnings report on Nov 12, 2024. Keep track of upcoming events with our Earnings Calendar.
ALLR net income for the last quarter is −1.63 M USD, while the quarter before that showed −3.84 M USD of net income which accounts for 57.61% change. Track more Allarity Therapeutics, Inc. financial stats to get the full picture.
No, ALLR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has 6.00 employees. See our rating of the largest employees — is Allarity Therapeutics, Inc. on this list?
Like other stocks, ALLR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Allarity Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Allarity Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Allarity Therapeutics, Inc. stock shows the sell signal. See more of Allarity Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.